Raymond James Trust’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,996
Closed -$624K 1158
2020
Q4
$624K Buy
3,996
+96
+2% +$15K 0.02% 469
2020
Q3
$446K Buy
3,900
+445
+13% +$50.9K 0.02% 527
2020
Q2
$388K Buy
3,455
+795
+30% +$89.3K 0.02% 555
2020
Q1
$239K Buy
2,660
+636
+31% +$57.1K 0.01% 644
2019
Q4
$219K Buy
+2,024
New +$219K 0.01% 847
2019
Q3
Sell
-2,611
Closed -$342K 979
2019
Q2
$342K Buy
2,611
+204
+8% +$26.7K 0.02% 566
2019
Q1
$325K Sell
2,407
-247
-9% -$33.4K 0.02% 576
2018
Q4
$259K Sell
2,654
-29
-1% -$2.83K 0.02% 610
2018
Q3
$373K Buy
2,683
+271
+11% +$37.7K 0.02% 545
2018
Q2
$299K Buy
2,412
+80
+3% +$9.92K 0.02% 622
2018
Q1
$260K Sell
2,332
-361
-13% -$40.2K 0.02% 579
2017
Q4
$322K Buy
2,693
+561
+26% +$67.1K 0.02% 520
2017
Q3
$299K Buy
2,132
+456
+27% +$64K 0.02% 535
2017
Q2
$204K Sell
1,676
-635
-27% -$77.3K 0.02% 661
2017
Q1
$281K Sell
2,311
-1,424
-38% -$173K 0.02% 520
2016
Q4
$457K Sell
3,735
-200
-5% -$24.5K 0.04% 375
2016
Q3
$483K Sell
3,935
-333
-8% -$40.9K 0.04% 344
2016
Q2
$499K Buy
4,268
+643
+18% +$75.2K 0.04% 331
2016
Q1
$505K Buy
3,625
+32
+0.9% +$4.46K 0.05% 327
2015
Q4
$686K Buy
3,593
+2,109
+142% +$403K 0.06% 278
2015
Q3
$232K Buy
1,484
+271
+22% +$42.4K 0.03% 502
2015
Q2
$219K Buy
+1,213
New +$219K 0.02% 551
2015
Q1
Sell
-1,103
Closed -$204K 669
2014
Q4
$204K Sell
1,103
-285
-21% -$52.7K 0.02% 566
2014
Q3
$230K Buy
+1,388
New +$230K 0.03% 512
2014
Q2
Sell
-1,394
Closed -$212K 635
2014
Q1
$212K Buy
+1,394
New +$212K 0.03% 512